A qualitative synthesis of trials promoting physical activity behaviour change among post-treatment breast cancer survivors

- Short, Camille E., James, Erica L., Stacey, Fiona, Plotnikoff, Ronald C.

Consensus on breast cancer cell lines classification for an effective and efficient clinical decision-making

- Milioli, H. H., Tishchenko, I., Riveros, C., Sakoff, J., Berretta, R., Moscato, P.

Genetic markers in breast cancer - how far have we come from BRCA1?

- Avery-Kiejda, Kelly A., Wong, Michelle W., Scott, Rodney J.

HER2 status predicts for upfront AI benefit: a TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

- Bartlett, John M. S., Ahmed, Ikhlaaq, Brookes, Cassandra L., Forbes, John F., Viale, Giuseppe, Cuzick, Jack, Dowsett, Mitchell, Rea, Daniel W., Regan, Meredith M., Sestak, Ivana, Mallon, Elizabeth A., Dell'Orto, Patrizia, Thürlimann, Beat, Seynaeve, Caroline, Putter, Hein, Van de Velde, Cornelis J. H.

Novel genes associated with lymph node metastasis in triple negative breast cancer

- Mathe, Andrea, Wong-Brown, Michelle, Morten, Brianna, Forbes, John F., Braye, Stephen G., Avery-Kiejda, Kelly A., Scott, Rodney J.

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

- Cuzick, Jack, Sestak, Ivana, Baum, Michael, Buzdar, Aman, Howell, Anthony, Dowsett, Mitch, Forbes, John F.

ProNGF, NGF and their receptors in tumour innervation and progression: a study in breast and thyroid cancers

- Faulkner, Sam

Methoxyphenylcipro induces antitumor activity in human cancer cells

- Mhaidat, Nizar M., Qandil, Amjad M., Al-Balas, Qosay A., Hassan, Mohammad A., Jaradat, Saied A., Matalkah, Ahmad M., Thorne, Rick T.

Physical activity and health literacy in women diagnosed with breast cancer

- Plummer, Leigh Clair

The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low ∆40p53:p53 ratio and better outcome

- Morten, Brianna C., Wong-Brown, Michelle W., Scott, Rodney J., Avery-Kiejda, Kelly A.

Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (Part 2): multicenter randomized controlled trial

- Zhu, Jiemin, Ebert, Lyn, Liu, Xiangyu, Wei, Di, Chan, Sally Wai-Chi

Impact of CYO19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

- Johansson, Harriet, Gray, Kathryn P., Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A., TEXT principal investigators,, Pagani, Olivia, Chirgwin, Jaqueline, Francis, Prudence, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf

PRONGF/NGF and nerve infiltration in prostate and breast cancer

- Pundavela, Jay

Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase

- Li, Yang, Liu, Hao, Huang, Ying Ying, Pu, Long Jian, Zhang, Xu Dong, Jiang, Chen Chen, Jiang, Zhi Wen

Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006

- Woods, Laura M., Rachet, Bernard, O'Connell, Dianne, Lawrence, Gill, Coleman, Michel P.

The association between age, comorbidities and use of radiotherapy in women with breast cancer: implications for survival

- Efird, Jimmy T., Hunter, Sharyn, Chan, Sally, Jeong, Sarah, Thomas, Susan L., Jindal, Charulata, Biswas, Tithi

Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V

- Colleoni, Marco, Sun, Zhuoxin, Goldhirsch, Aron, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S.

Low-dose oral cyclophosphamide and methotrexate maintenance for hormone receptor-negative early breast cancer: International Breast Cancer Study Group Trial 22-00

- Colleoni, Marco, Gray, Kathryb P., Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio

Adjuvant systemic treatment of premenopausal women with hormone receptor-positive early breast cancer: lights and shadows

- Regan, Megan, Fleming, Gini, Walley, Barbara, Francis, Prudence, Pagani, Olivia

Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer

- Avery-Kiejda, Kelly A., Braye, Stephen G., Mathe, Andrea, Forbes, John F., Scott, Rodney J.